Volume 8, Number 11—November 2002
Tuberculosis Genotyping Network, United States
Estimated Costs of False Laboratory Diagnoses of Tuberculosis in Three Patients
|Patient||Public sectorb||Private sectorc|
|Direct medical costs|
|TB medications||Outpatient visits TB medications and PPD DOT provision Tests and procedures Contact investigations Hospitalizations||Outpatient visits TB medications and PPD Tests and procedures Contact investigations Hospitalizations|
|Direct nonmedical costs|
|Case managementd Overheade|
aTB, tuberculosis; PPD, purified protein derivative of tuberculin; DOT, directly observed therapy.
bLocal and state public health departments, public health hospital and laboratory, and county and state correctional facilities.
cPrivate physicians, hospitals, and laboratories.
dHealth department case management and administrative support.
eOverhead costs, including rent, utilities, and supplies.
- Page created: July 19, 2010
- Page last updated: July 19, 2010
- Page last reviewed: July 19, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)